SOURCE: Implant Sciences

Implant Sciences

September 01, 2010 09:57 ET

Implant Sciences Appoints Bruce Bower as Senior Vice President

Brings 25 Years of Global High-Tech Sales Leadership

WILMINGTON, MA--(Marketwire - September 1, 2010) - Implant Sciences Corporation (PINKSHEETS: IMSC) a high technology supplier of systems and sensors for homeland security and defense markets, today announced the appointment of Bruce Bower into the newly created position of Senior Vice President. In this position, Mr. Bower will lead Implant Sciences' marketing and sales efforts.

Mr. Bower has more than 25 years of sales, sales management, marketing and executive management experience with technology companies selling hardware and software solutions to enterprise and government customers worldwide. Prior to joining Implant Sciences he was Vice President, Sales and Marketing and then promoted to President and CEO of Teloquent Communications, a computer software company. Previous to Teloquent, Mr. Bower served as Vice President, Sales and Marketing, and later promoted to President and CEO for MultiLink, a telecommunications company. He also held Sales Management, Product Management, and General Management positions with ROLM and IBM. He holds a Master of Business Administration from Boston University.

Implant Sciences CEO Glenn Bolduc commented, "Bruce has repeatedly demonstrated his skills in leading sales teams that successfully bring new technologies into the global marketplace. He's focused on creating the highest margins and cash flows for his companies while providing value pricing to customers. We are very pleased to have Bruce on board and feel he will be an important asset in our company's growth."

"I believe Implant Sciences is very well positioned to capitalize on growth in the Safety, Security and Defense markets both through expanded sales of its flagship product, Quantum Sniffer, as well as through the introduction of new products further extending our patent protected intellectual property. This is a very compelling global growth industry and I am excited to play a role in leading Implant Sciences into capturing greater market share," added Bruce Bower, Sr. Vice President, Implant Sciences.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Science's QS-H100 and QS-H150 Portable Explosives Detectors have been Designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:
    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact